SKI Market

Indian Indices

Nifty

24,718.60 -169.60
(-0.68%)

Sensex

81,766.50 647.90
( 0.80%)

Bank Nifty

55,527.35 -555.20
( -0.99%)

Nifty IT

38,469.25 8.95
( 0.02%)

Global Indices

Nasdaq

42,214.73 -773.90
(-1.80%)

Dow Jones

5,997.34 -68.92
(-1.14%)

Hang Seng

38,275.58 441.33
(1.17%)

Nikkei 225

8,850.63 -34.29
(-0.39%)

Forex

USD-INR

85.55 0.07
(0.08%)

EUR-INR

98.89 0.98
(1.00%)

GBP-INR

116.24 0.70
(0.61%)

JPY-INR

0.60 0.01
(0.86%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

56.2513194

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

35.04

3586.91

EPS(TTM)

Face Value()

Div & Yield %

9.15

1.62

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	365.47	311.53	272.80	283.47	247.35	222.09
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	365.47	311.53	272.80	283.47	247.35	222.09
Other Income	58.81	9.81	9.08	6.82	9.00	5.61
Stock Adjustments	7.83	-1.48	13.52	-1.27	5.68	-5.40
Total Income	432.11	319.86	295.40	289.02	262.03	222.30
EXPENDITURE :
Raw Materials	139.56	121.43	112.72	95.03	94.44	80.43
Power & Fuel Cost	22.73	19.58	16.19	11.53	10.95	10.21
Employee Cost	49.97	41.42	39.32	34.23	32.61	35.07
Other Manufacturing Expenses	18.57	14.52	13.53	9.25	9.08	7.36
Selling & Administrative Expenses	33.05	32.37	28.66	28.49	25.74	27.93
Miscellaneous Expenses	22.95	5.64	3.08	2.81	3.26	2.80
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	286.83	234.97	213.49	181.35	176.08	163.81
Operating Profit	145.28	84.89	81.90	107.67	85.96	58.49
Interest	0.39	0.33	0.27	0.24	1.29	2.72
Gross Profit	144.89	84.56	81.63	107.43	84.67	55.77
Depreciation	10.90	10.28	9.56	9.01	8.81	8.56
Profit Before Tax	133.99	74.28	72.07	98.42	75.86	47.21
Tax	26.95	18.25	18.02	24.84	19.39	11.96
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.08	0.50	-0.46	2.57	-1.49	0.01
Reported Net Profit	108.12	55.53	54.51	71.01	57.96	35.23
Extraordinary Items	-15.13	-0.59	0.89	0.51	0.00	-0.05
Adjusted Net Profit	123.25	56.12	53.62	70.50	57.96	35.28
Adjustment below Net Profit	-0.10	0.49	0.02	-0.03	-1.31	-0.61
P & L Balance brought forward	417.50	372.66	328.19	263.91	213.96	184.92
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	55.91	11.18	10.06	6.70	6.70	5.58
P & L Balance carried down	469.61	417.50	372.66	328.19	263.91	213.96
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	255.00	50.00	50.00	45.00	30.00	30.00
Dividend Per Share(Rs)	5.10	1.00	1.00	0.90	0.60	0.60
Earnings Per Share-Unit Curr	9.67	4.97	4.88	6.36	5.19	3.16
Earnings Per Share(Adj)-Unit Curr	9.67	4.97	4.88	6.36	5.19	3.16
Book Value-Unit Curr	51.91	46.98	42.97	38.97	33.17	28.61
Book Value(Adj)-Unit Curr	51.91	46.98	42.97	38.97	33.17	28.61

24,718.60 -169.60 (-0.68%)

81,766.50 647.90 ( 0.80%)

55,527.35 -555.20 ( -0.99%)

38,469.25 8.95 ( 0.02%)

42,214.73 -773.90 (-1.80%)

5,997.34 -68.92 (-1.14%)

38,275.58 441.33 (1.17%)

8,850.63 -34.29 (-0.39%)

85.55 0.07 (0.08%)

98.89 0.98 (1.00%)

116.24 0.70 (0.61%)

0.60 0.01 (0.86%)